Sickle Cell Disease in Sub‐Saharan Africa: Progress and Potential
American Journal of Hematology · 2026-04 · 101 (S1) · 3-4
DOI: 10.1002/ajh.70242 ↗Kurz gefasst
Editorial in der Zeitschrift American Journal of Hematology, online erschienen am 14.03.2026. Verfasst von Russell E Ware. Beteiligte Einrichtung: Division of Hematology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
R.E.W. has received research donations from Bristol-Myers Squibb, Theravia, and Hemex Health; is an advisor to Nova Laboratories, Theravia, and Octapharma; serves on a DSMB for NHLBI and Vaxart Inc. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.
Autor:innen und Institutionen
- Division of Hematology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
- Global Health Center, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
- University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
ORCID-Profile: Russell E Ware
Zitieren
APA
Ware, R. E. (2026). Sickle Cell Disease in Sub‐Saharan Africa: Progress and Potential. American Journal of Hematology, 101(S1), 3-4. https://doi.org/10.1002/ajh.70242
Vancouver
Ware RE. Sickle Cell Disease in Sub‐Saharan Africa: Progress and Potential. American Journal of Hematology. 2026;101(S1):3-4. doi:10.1002/ajh.70242
BibTeX
@article{Ware2026,
author = {Ware, Russell E},
title = {Sickle Cell Disease in Sub‐Saharan Africa: Progress and Potential},
journal = {American Journal of Hematology},
year = {2026},
volume = {101},
number = {S1},
pages = {3--4},
doi = {10.1002/ajh.70242}
}
EUVIMED